-
News | 2020.04.28
COVID-19 pandemic: The Institut Pasteur International Network collective effort
To this day, SARS-CoV2, the virus responsible for COVID-19 pandemic, has been identified in more than 180 countries. It unfolded a once-in-a-century public health crisis, through his extensive impact on global economy directly caused by confinement measures. To confront these challenges, the 32 member institutes of the Institut Pasteur International Network (IPIN) are swinging into...
-
News | 2020.04.28
COVID-19 pandemic: The Institut Pasteur International Network collective effort
To this day, SARS-CoV2, the virus responsible for COVID-19 pandemic, has been identified in more than 180 countries. It unfolded a once-in-a-century public health crisis, through his extensive impact on global economy directly caused by confinement measures. To confront these challenges, the 32 member institutes of the Institut Pasteur International Network (IPIN) are swinging into...
-
News | 2020.04.30
A comprehensive analysis of midbodies, bridges between dividing cells
Scientists at the Institut Pasteur have developed a method to isolate midbodies, bridges that link cells undergoing cytokinesis. Using the latest mass spectrometry methods, they produced a comprehensive inventory and revealed the presence of 1,732 proteins! By characterizing three of these proteins in detail, they pinpointed novel molecular mechanisms involved in both cell division and virus...
-
Document de presse | 2020.04.21
COVID-19: mathematical model indicates that between 3% and 7% of French people have been infected
The SARS-CoV-2 global pandemic has resulted in extreme measures, with several countries imposing a lockdown on their residents. Like much of the rest of Europe, France has been badly affected by the outbreak; it introduced lockdown measures on March 17 with the aim of significantly reducing the circulation of the virus among the population. To help understand and manage this unprecedented health...
-
Page avancée | 2020.05.05
Pasteur courses
Pasteur courses
-
Document de presse | 2020.04.30
Revealing how SARS-CoV-2 hijacks human cells; points to drugs with potential to fight COVID-19 and a drug that aids its infectious growth
An international effort including researchers from University of California San Francisco (UCSF), Gladstone Institutes, Icahn School of Medicine at Mount Sinai and Institut Pasteur (Paris) unveils promising compounds for clinical testing against COVID-19. The study, led by UCSF Quantitative Biosciences Institute Director, Nevan Krogan, PhD, reveals that some drugs may fight COVID-19...
-
Document de presse | 2020.05.07
Achilles’ heel for reseeding of the viral reservoir after stem cell transplantation in people with HIV
Current HIV treatments efficiently block viral multiplication but cannot cure infection as they do not target HIV infected cells. HIV cure or profound HIV remission have been described in three persons with HIV who underwent allogeneic stem cell transplantation to treat severe blood cancers. However, this procedure has not eradicated the virus in other persons. A work led by scientists from the...
-
Page avancée | 2020.05.12
Pasteur workshops
-
News | 2020.05.14
LuLISA project, bioluminescence as a tool for human diagnostics, from allergy to Covid19
The LuLISA (Luciferase-Linked ImmunoSorbent Assay) research project aims developing high throughput serological tests for epidemiological studies at local, regional or nation scales. In a recent scientific publication, concerning the detection and dosing of IgE specific to several allergens in patients’ blood samples, the use of LuLISA proves to be a vastly improved detection method in...
-
News | 2020.07.27
A new biotechnology tool to tackle antibiotic resistance
Designing effective new molecules to tackle infectious diseases is a difficult process that currently represents a huge challenge for scientists, especially given the rise in bacterial resistance to antibiotics. Scientists from the Institut Pasteur's Bacterial Genome Plasticity Unit have responded to this challenge by developing a new biotechnological tool which bypasses the sampling limitations...
